Lymph node study for kidney cancer patients
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at lymph nodes in people with known or suspected kidney cancer to learn more about the disease. It may help researchers understand how kidney cancer affects the lymph system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have known or suspected kidney cancer.
- You are not pregnant or breastfeeding.
- You do not have an allergy to iodine.
- You are being seen at Yale New Haven Hospital or Smilow Cancer Hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study looks at the biology of kidney cancer that has spread to lymph nodes)Skip and tests tumor tissue to find which drugs might work best. By studying the tumor's genes and proteins, doctors hope to find more personalized treatment options for people with this condition.
This study is for people with high-risk kidney cancer who are having their whole kidney removed. It compares surgery alone versus surgery plus removing lymph nodes from the tumor area to see if removing the nodes helps control the cancer better.
This study looks at how your immune system and cancer cells interact. It may help doctors understand your cancer better and could lead to new treatments.
This study looks at whether a simple blood test can detect tiny bits of kidney cancer DNA after surgery. If successful, it could help doctors spot a return of cancer earlier than scans alone.
This study tests whether a simple blood test that tracks tumor DNA (called ctDNA) can help predict how well immunotherapy will work for people with non-clear cell kidney cancer. If you are about to start immunotherapy for advanced disease, this study could help your doctor better understand your treatment response.
This study collects blood and tissue samples from people with cancer or suspected cancer, or from their blood relatives. Researchers use these samples to better understand cancer and develop new treatments.
Hear when a new Renal Cell Carcinoma (RCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.